Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human IGFBP7 aa 100-200 (Cysteine residue). The exact sequence is proprietary.
Database link: Q16270
This product is a recombinant rabbit monoclonal antibody.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
Our Abpromise guarantee covers the use of ab171085 in the following tested applications.
|WB||1/1000 - 1/10000. Predicted molecular weight: 29 kDa.|
|IHC-P||1/50 - 1/100.|
|ICC/IF||1/250 - 1/500.|
|Flow Cyt||1/250 - 1/500. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.|
Flow cytometric analysis of permeabilized 293T cells labeling IGFBP7 with ab171085 at 1/250 dilution (red) compared to a rabbit IgG negative control (green).
Immunofluorescent analysis of MCF7 cells labeling IGFBP7 with ab171085 at 1/250 dilution.
Immunohistochemical analysis of paraffin-embedded Human prostate tissue labeling IGFBP7 with ab171085 at 1/50 dilution.
Immunohistochemical analysis of paraffin-embedded Human pancreas tissue labeling IGFBP7 with ab171085 at 1/50 dilution.